Putnam Investments
http://www.putnam.com/Putnam Investments is a global money management firm offering institutional portfolios;
401(k)s, IRAs, and other retirement plans; mutual funds; variable annuities; and alternative investments for institutions and high-net-worth investors. The firm has over 70 years of experience and manages more than $160 billion in assets.
View Older Stories View More Recent Stories
-
Form NPORT-P PUTNAM TAX FREE INCOME For: Jul 31
-
Form NPORT-P PUTNAM FUNDS TRUST For: Jul 30
-
Form NPORT-P PUTNAM PREMIER INCOME For: Jul 31
-
Form NPORT-P PUTNAM INVESTMENT FUNDS For: Jul 31
-
Form NPORT-P Putnam Target Date Funds For: Jul 31
-
Form NPORT-P Putnam Target Date Funds For: Jul 31
-
Form NPORT-P Putnam Target Date Funds For: Jul 31
-
Form NPORT-P Putnam Target Date Funds For: Jul 31
-
Form NPORT-P Putnam Target Date Funds For: Jul 31
-
Form NPORT-P Putnam Target Date Funds For: Jul 31
-
Form NPORT-P Putnam Target Date Funds For: Jul 31
-
Form NPORT-P Putnam Target Date Funds For: Jul 31
-
Form NPORT-P PUTNAM FUNDS TRUST For: Jul 31
-
Form NPORT-P Putnam Target Date Funds For: Jul 31
-
Form NPORT-P Putnam Target Date Funds For: Jul 31
-
TMMWV Celebrates 25 Years, Nearly 20 Million Powertrains Built; Innovation, Advanced Manufacturing to Guide Future Production
-
Putnam Announces Distribution Rates for Open End Funds
-
ENT and Allergy Associates, LLP To Relocate and Enhance Its Presence on the East Side of Manhattan
-
FOMC teases start of taper "soon"
-
Clover Health Investments (CLOV) Announces CMS Approves its Expansion Plans for 2022
-
CMS Approves Clover Health's Expansion Plans for 2022
-
CMS Approves Clover Health's Expansion Plans for 2022
-
Dollar choppy after Fed statement, Evergrande exhale lifts risk-sensitive currencies
-
ENT and Allergy Associates, LLP Continues to Bolster Its Central New Jersey Roster With the Addition of Seasoned Otolaryngologist Thomas F. Mazzoni, DO
-
Form 24F-2NT PUTNAM INTERNATIONAL For: Jun 30
-
Form 24F-2NT PUTNAM SUSTAINABLE LEADE For: Jun 30
-
Form 24F-2NT PUTNAM FUNDS TRUST For: Jun 30
-
Archer Begins Trading on the New York Stock Exchange Under the Symbol “ACHR”
-
Ginkgo Bioworks to Begin Trading Today as NYSE: DNA with Over $1.6 Billion in Proceeds
-
Putnam Announces Distribution Rates for Open End Funds
-
ENT and Allergy Associates, LLP Announces Promotion of Seven Associate Allergists to Partner
-
First Sentier Investors appoints investment management veteran Jamie Damon to senior institutional sales role
-
Institutional & Public Pension Plans Veteran Tim Stidham to Lead Global Distribution Sales and Marketing for TriLinc Global
-
Soaring Eagle (SRNG) announces business combination with Ginkgo was overwhelmingly approved in shareholder vote
-
Ginkgo Bioworks to Go Public with Over $1.6 Billion in Proceeds
-
Dan Singer, Co-President of Robison, Says Equipment Sales Still Going Strong Post Pandemic
-
Village of Elmsford joins the Empire State Purchasing Group
-
Gen.G Announces Second Annual Gen. G Foundation Scholarship Recipients
-
Clarus Therapeutics Closes Transaction With Blue Water, Debuts as a Publicly Traded Company to Develop Androgen and Metabolic Therapies
-
Imperial Capital Names Peter Meyer as Head of Fixed Income Sales & Trading
-
Imperial Capital Names Peter Meyer as Head of Fixed Income Sales & Trading
-
HealthEquity Reports Second Quarter Ended July 31, 2021 Financial Results
-
John Fareri, CEO of Fareri Associates, Announces Joining Board of Directors of Hudson Valley Economic Development Corp.
-
Putnam Investments Announces 19(a) Notices for Closed-End Municipal Funds
-
Putnam Investments Announces 19(a) Notices for Closed-End Funds
-
Form N-MFP2 PUTNAM INVESTMENT FUNDS For: Aug 31
-
Form N-MFP2 PUTNAM VARIABLE TRUST For: Aug 31
-
Form N-MFP2 PUTNAM MONEY MARKET FUND For: Aug 31
-
Form 4 Community Bankers Trust For: Sep 01 Filed by: PUTNAM EUGENE S JR
-
Form 3 EVO Transportation & For: Jul 22 Filed by: PUTNAM EUGENE S JR

